Understanding how viral RNA structures help viruses infect cells
Functional implications of structural heterogeneity in a viral RNA translation initiation element
This study is looking at how certain parts of the RNA in viruses like Hepatitis C help them start an infection even when the body's defenses are down, and it hopes to find new ways to treat these infections.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York Structural Biology Center NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10995778 on NIH RePORTER |
What this research studies
This research investigates how specific RNA structures in viruses, particularly those similar to the Hepatitis C Virus (HCV), enable these viruses to initiate infection even when the host's cellular machinery is suppressed. By using advanced computational and biochemical techniques, the study aims to identify and characterize the structural diversity of these RNA elements, known as Internal Ribosome Entry Sites (IRESs). This understanding could lead to insights into how these viruses survive and proliferate, potentially informing new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by viral infections, particularly those caused by RNA viruses like Hepatitis C.
Not a fit: Patients with non-viral related health issues or those not affected by RNA viruses may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel antiviral therapies targeting the mechanisms that allow viruses to hijack cellular processes.
How similar studies have performed: Previous research has shown success in understanding viral RNA structures, indicating that this approach has potential for significant findings.
Where this research is happening
New York, United States
- New York Structural Biology Center — New York, United States (Active)
Researchers
- Principal investigator: Segar, Katherine — New York Structural Biology Center
- Study coordinator: Segar, Katherine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.